226 related articles for article (PubMed ID: 19998053)
1. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes.
Cohen-Nahum K; Saidel-Odes L; Riesenberg K; Schlaeffer F; Borer A
Infection; 2010 Feb; 38(1):41-6. PubMed ID: 19998053
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance.
Korytny A; Riesenberg K; Saidel-Odes L; Schlaeffer F; Borer A
Infect Dis (Lond); 2016; 48(6):428-31. PubMed ID: 26763474
[TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
[TBL] [Abstract][Full Text] [Related]
4. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
[TBL] [Abstract][Full Text] [Related]
5. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
6. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
[TBL] [Abstract][Full Text] [Related]
8. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.
Tsai HY; Chen YH; Tang HJ; Huang CC; Liao CH; Chu FY; Chuang YC; Sheng WH; Ko WC; Hsueh PR
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):222-6. PubMed ID: 25139843
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.
Tumbarello M; Trecarichi EM; Fiori B; Losito AR; D'Inzeo T; Campana L; Ruggeri A; Di Meco E; Liberto E; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2012 Jun; 56(6):3224-31. PubMed ID: 22450979
[TBL] [Abstract][Full Text] [Related]
10. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
11. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.
Shikh-Bardsiri H; Shakibaie MR
Pak J Biol Sci; 2013 Nov; 16(22):1496-502. PubMed ID: 24511691
[TBL] [Abstract][Full Text] [Related]
13. Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria: Case-control Study.
Amin O; Prestel C; Gonzalez MD; Lyon T; Shane A; Jaggi P; Tippett A; Yildirim I
Pediatr Infect Dis J; 2020 Mar; 39(3):211-216. PubMed ID: 32032306
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
Milovanovic T; Dumic I; Veličkovic J; Lalosevic MS; Nikolic V; Palibrk I
BMC Infect Dis; 2019 Feb; 19(1):141. PubMed ID: 30755176
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
Zanichelli V; Huttner A; Harbarth S; Kronenberg A; Huttner B; Swiss Centre For Antibiotic Resistance Anresis
Swiss Med Wkly; 2019 Jul; 149():w20110. PubMed ID: 31340052
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of
Decôme M; Cuq B; Fairbrother JH; Gatel L; Conversy B
Can J Vet Res; 2020 Oct; 84(4):252-258. PubMed ID: 33012973
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic resistance of community-acquired uropathogenic Enterobacteriaceae isolated in Sfax (Tunisia)].
Smaoui S; Abdelhedi K; Marouane C; Kammoun S; Messadi-Akrout F
Med Mal Infect; 2015 Aug; 45(8):335-7. PubMed ID: 26362517
[No Abstract] [Full Text] [Related]
18. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Biofilm Forming Capability and Antibiotic Resistance in
Egbule OS; Konye OP; Iweriebor BC
Pak J Biol Sci; 2024 Apr; 27(5):268-275. PubMed ID: 38840467
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
Khan AU; Musharraf A
Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
